IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.653
AS - Asia 1.039
EU - Europa 852
SA - Sud America 156
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 53
OC - Oceania 8
Totale 3.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.568
IT - Italia 469
SG - Singapore 392
CN - Cina 177
IN - India 124
BR - Brasile 118
GB - Regno Unito 94
DE - Germania 91
VN - Vietnam 69
CA - Canada 50
BD - Bangladesh 46
HK - Hong Kong 44
FI - Finlandia 41
NL - Olanda 29
ID - Indonesia 26
PK - Pakistan 26
JO - Giordania 25
SE - Svezia 22
SA - Arabia Saudita 20
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
FR - Francia 13
EG - Egitto 12
IQ - Iraq 12
JP - Giappone 12
CO - Colombia 11
UA - Ucraina 11
AR - Argentina 9
CZ - Repubblica Ceca 9
MY - Malesia 9
RU - Federazione Russa 9
TR - Turchia 9
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
IR - Iran 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PT - Portogallo 7
GT - Guatemala 6
KE - Kenya 6
PL - Polonia 6
AT - Austria 5
ET - Etiopia 5
HN - Honduras 5
KR - Corea 5
LB - Libano 5
RO - Romania 5
CY - Cipro 4
EC - Ecuador 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CH - Svizzera 3
MA - Marocco 3
NI - Nicaragua 3
PH - Filippine 3
VE - Venezuela 3
AL - Albania 2
CR - Costa Rica 2
HR - Croazia 2
LK - Sri Lanka 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.763
Salva come PNG Salva come JPEG
Città #
San Jose 299
Ashburn 196
Singapore 196
Chandler 110
Dallas 76
Santa Clara 76
Munich 63
Chicago 53
Council Bluffs 53
Bengaluru 47
Hefei 46
London 44
Beijing 39
Hong Kong 34
Milan 32
Turku 29
New York 28
Los Angeles 25
Phoenix 25
Princeton 25
Lawrence 24
Ho Chi Minh City 23
Rome 23
Catanzaro 18
Amman 17
Hanoi 16
Naples 16
Boardman 14
Jeddah 14
Carbonia 12
Helsinki 12
Parma 12
San Nicola Manfredi 12
São Paulo 12
Atlanta 11
Montreal 11
San Francisco 11
Buffalo 10
Spezzano della Sila 10
Tokyo 10
Bologna 9
Chennai 9
Palermo 9
Wilmington 9
Catania 8
Delhi 8
Frankfurt am Main 8
Irbid 8
Madrid 8
Cosenza 7
Des Moines 7
Kaunas 7
Ottawa 7
Afragola 6
Da Nang 6
Ercolano 6
Hyderabad 6
Kuala Lumpur 6
Riyadh 6
Santo Stefano di Rogliano 6
Seattle 6
Sezze 6
Ahmedabad 5
Boston 5
Brooklyn 5
Cape Town 5
Cardiff 5
Dublin 5
Haiphong 5
Kyiv 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Nairobi 5
Olomouc 5
Orem 5
Pune 5
Sacramento 5
Toronto 5
Warsaw 5
Addis Ababa 4
Biên Hòa 4
Dhaka 4
Glasgow 4
Guatemala City 4
Hanover 4
Islamabad 4
Istanbul 4
Johannesburg 4
Lima 4
Manchester 4
Melbourne 4
Nicosia 4
Oristano 4
Perugia 4
Redmond 4
Richmond 4
Stockholm 4
Tanta 4
Tashkent 4
Totale 2.112
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 506
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 154
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 128
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 125
miR-22 suppresses DNA ligase III addiction in multiple myeloma 116
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 109
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 101
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 97
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 88
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 88
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 86
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 84
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 84
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 82
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 81
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 80
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 80
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 80
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 76
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 76
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 74
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 74
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 73
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 69
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 69
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 67
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 63
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 63
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 62
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 62
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 61
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 60
Ethical Perspectives on Pharmacogenomic Profiling 56
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 56
Mmrf-commpass data integration and analysis for identifying prognostic markers 56
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 54
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 53
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 52
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 52
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 47
The EASY-NET research programme: background, structure, and methodology 45
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 44
null 43
The potential role of miRNAs in multiple myeloma therapy 41
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 40
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 37
null 31
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 16
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 15
Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke 15
null 4
Totale 3.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022123 0 0 0 22 5 0 4 21 34 15 17 5
2022/2023394 55 25 28 13 45 26 6 25 49 40 55 27
2023/2024476 90 33 42 39 45 71 25 41 10 18 27 35
2024/2025876 75 20 27 37 64 119 64 55 55 21 142 197
2025/20261.536 108 154 126 149 168 80 211 74 157 147 96 66
2026/2027371 30 65 168 108 0 0 0 0 0 0 0 0
Totale 3.875